Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Perrigo Company Reaffirms Fiscal 2024 Adjusted Diluted EPS Outlook Of $2.50-$2.65 Vs. $2.25 Estimate

Author: Benzinga Newsdesk | August 02, 2024 06:39am

Fiscal Year 2024 Outlook:

  • Company updates its fiscal 2024 organic net sales growth outlook versus the prior year to -3% to -1%, from +1% to +3%, and total net sales growth outlook to -5% to -3% from flat, due primarily to lower seasonal demand experienced in the first half of 2024 and expected lower distribution in U.S. store brand in the second half of 2024.

      
  • The Company reaffirms its fiscal 2024 adjusted diluted EPS outlook of $2.50-$2.65, as increased profitability from faster than anticipated recovery in the infant formula business, improved product mix and lower selling expenses are expected to be offset by flow-through from the updated net sales outlook. 

Posted In: PRGO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist